ACCURAY Aktie

>ACCURAY Aktienkurs

0.496 EUR +5.5% (TradegateBSX)

Ask: 0.462 EUR / 8641 Stück

Bid: 0.45 EUR / 8904 Stück

Tagesumsatz: 2560 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

ACCURAY Aktie über LYNX handeln

Intraday

1 Jahr

>ACCURAY Performance

1 Woche: +6,7%

1 Monat: -28,1%

3 Monate: -40,6%

6 Monate: -61,6%

1 Jahr: -75,7%

laufendes Jahr: -27,6%

>ACCURAY Aktie

Name:

ACCURAY INC. DL -,001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US0043971052 / A0MKWM

Symbol/ Ticker:

XEJ (Frankfurt) / ARAY (NASDAQ)

Kürzel:

FRA:XEJ, ETR:XEJ, XEJ:GR, NASDAQ:ARAY

Index:

Webseite:

http://www.accuray.com

Profil:

Accuray Incorporated is a medical device company specializing in the development and sale of precise tumor treatments. Primarily known for its innovative radiation therapy systems, the company develop..
>Volltext..

Marktkapitalisierung:

53.95 Mio. EUR

Unternehmenswert:

166.51 Mio. EUR

Umsatz:

370.79 Mio. EUR

EBITDA:

0.6 Mio. EUR

Nettogewinn:

-30.23 Mio. EUR

Gewinn je Aktie:

-0.25 EUR

Schulden:

147.84 Mio. EUR

Liquide Mittel:

35.53 Mio. EUR

Operativer Cashflow:

3.86 Mio. EUR

Bargeldquote:

0.21

Umsatzwachstum:

-15%

Gewinnwachstum:

-618.15%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

1 Insider kaufte innerhalb der letzten 30 Tage Aktien im Wert von 103.797 USD.

Suchwörter:

ACCURAY

Letzte Datenerhebung:

21.02.26

>ACCURAY Kennzahlen

Aktien/ Unternehmen:

Aktien: 118.78 Mio. St.

Frei handelbar: 95.16%

Leerverk. Aktien: 4.26%

Rückkaufquote: -2.02%

Mitarbeiter: 990

Umsatz/Mitarb.: 0.39 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 405.61%

Bewertung:

KGV: -

KGV lG: -

KUV: 0.15

KBV: 1.11

PEG-Ratio: -

EV/EBITDA: 278.73

Rentabilität:

Bruttomarge: 27.83%

Gewinnmarge: -8.15%

Operative Marge: -2.29%

Managementeffizenz:

Gesamtkaprendite: -7.69%

Eigenkaprendite: -70.32%

>ACCURAY Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Onkologie/ Krebs- Behandlung

>ACCURAY Chart & Kurs - NASDAQ

>ACCURAY News

20.02.26 - 23:01	Insiderhandel: Aufsichtsrat kauft Aktien von Accuray im Wert von 67199 USD (Insiderkauf)
	Mayer, Steven F. - Aufsichtsrat - Tag der Transaktion: 2026-02-18...

20.02.26 - 23:01	Insiderhandel: Aufsichtsrat kauft Aktien von Accuray im Wert von 36598 USD (Insiderkauf)
	Mayer, Steven F. - Aufsichtsrat - Tag der Transaktion: 2026-02-19...

05.02.26 - 00:15	Accuray resets 2026 outlook to $440M–$450M revenue and $22M–$25M adjusted EBITDA amid transformation plan (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

04.02.26 - 23:48	Accuray (ARAY) Q2 2026 Earnings Call Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

04.02.26 - 22:36	Accuray GAAP EPS of -$0.11 beats by $0.01, revenue of $102.2M beats by $1.34M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

04.02.26 - 22:09	Accuray Reports Fiscal 2026 Second Quarter Financial Results (PR Newswire)
	MADISON, Wis., Feb. 4, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2025. Key Highlights On December 15, 2025 the Company announced the first phase of comprehensive, strategic, operational, and......

21.01.26 - 22:06	Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026 (PR Newswire)
	MADISON, Wis., Jan. 21, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2026, ended December 31, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on February 4, 2026. The......

16.12.25 - 19:21	Radiation Therapy-Focused Accuray Details Workforce Reduction, Outsourcing In Major Transformation Push (Benzinga)
	Accuray outlines a restructuring plan aimed at $25 million in annual profit gains through cost cuts, workforce reduction and operational realignment. read more...

15.12.25 - 23:18	Accuray-Aktie legt nach Ankündigung eines 25-Millionen-Dollar-Sparprogramms zu (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

15.12.25 - 23:03	Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth (PR Newswire)
	Plan includes organizational realignment, rightsizing of cost structure, outsourcing, and sales enablement in order to enhance competitiveness and support long-term strategy. Workforce optimization actions will affect approximately 15% of the company's employees. Of the expected $25......

20.11.25 - 02:02	Insiderhandel: CEO kauft Aktien von Accuray im Wert von 19410 USD (Insiderkauf)
	La, Neve Stephen R. - Vorstand - Tag der Transaktion: 2025-11-19...

06.11.25 - 00:45	Accuray outlines transformation plan with adjusted EBITDA margin targets amid margin pressures and service revenue growth (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

05.11.25 - 23:42	Earnings Call: Accuray verfehlt Gewinnprognose deutlich, Aktie legt dennoch zu (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

05.11.25 - 22:27	Accuray GAAP EPS of -$0.18 misses by $0.12, revenue of $93.9M beats by $2.55M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

05.11.25 - 22:06	Accuray Reports Fiscal 2026 First Quarter Financial Results (PR Newswire)
	MADISON, Wis., Nov. 5, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2025. Key Highlights On October 20, 2025, the Company announced accelerated transformation efforts, including: Appointed Steve La Neve......

31.10.25 - 21:06	Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules (PR Newswire)
	MADISON, Wis., Oct. 31, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Stephen La Neve, the company's new Chief Executive Officer. As a material inducement to Mr. La Neve joining the company, and in......

28.10.25 - 12:39	Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025 (PR Newswire)
	MADISON, Wis., Oct. 28, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2026, ended September 30, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on November 5, 2025. The......

20.10.25 - 15:26	Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth (PR Newswire)
	Industry Veteran Steve La Neve Named Chief Executive Officer Suzanne Winter to Retire as President and CEO Company Appoints Steven F. Mayer as Transformation Board Sponsor Chan W. Galbato Nominated to Board of Directors MADISON, Wis., Oct. 20, 2025 /PRNewswire/ -- Accuray Incorporated......

08.10.25 - 13:36	Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System (PR Newswire)
	5D Clinics and Joint Venture Partner Icon Group Make Strides in Delivering on Commitment to Increasing Access to World-class Radiation Treatments for More Communities Across Australia. MADISON, Wis., Oct. 8, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that 5D......

30.09.25 - 13:39	Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care (PR Newswire)
	MADISON, Wis., Sept. 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced today the signing of a memorandum of understanding (MOU) to advance online adaptive radiotherapy (OART) on the Accuray......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Nie ist man stärker ein Gemeinschaftswesen als im Gefühl, der einzige Mensch auf der Welt zu sein. - Alfred Paul Schmidt

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram